MedTrace Logo

The Head and Neck Tumor Biobank

NCT01644786 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 419

Last updated 2025-10-02

No results posted yet for this study

Summary

The purpose of the biobank is to enable future genomic based research on this Head and Neck Cancer patient population. The investigators will try to identify tumor factors that will predict cancer-related outcome in order to improve the outcome prediction after treatment in a patient-individualized manner.

Conditions

Sponsors & Collaborators

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Bernd Kremer, MD, PhD · Maastricht University Medical Center

  • Bernd Lethaus, MD, PhD · Maastricht University Medical Center

  • Ernst-Jan Speel, MD, PhD · Maastricht University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2023-08-31
Completion
2025-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644786 on ClinicalTrials.gov